Valmark Advisers’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Valmark Advisers's ELV Position: Q2 2026 in Review
Valmark Advisers reduced its Elevance Health (ELV) stake by 2.9% in Q2 2026, selling an estimated $13.7K and leaving 1,254 shares worth $485K. The position accounts for 0.01% of the portfolio, ranked #505.
Valmark Advisers first reported a position in ELV in Q4 2021 and has held it in 19 quarters since. The position peaked at $979K in Q2 2024. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Valmark Advisers held 1,254 shares of Elevance Health worth $485K as of Q2 2026.
- Valmark Advisers sold 37 Elevance Health shares in Q2 2026, an estimated $13.7K.
- Elevance Health made up 0.01% of Valmark Advisers's portfolio in Q2 2026, its #505 holding.
- Valmark Advisers first reported a position in Elevance Health in Q4 2021 and has held it in 19 quarters since.
- Valmark Advisers's Elevance Health position peaked at $979K in Q2 2024.
- 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Valmark Advisers's 13F filing for Q2 2026, filed 6 Aug 2026.